HCPLive
MARCH 24, 2024
A new review considers how SGLT2 inhibitors like dapagliflozin and empagliflozin have been shown to clinically improve gout while reducing its cardiometabolic and renal comorbidities.
Heart Sisters
MARCH 24, 2024
Résumé virtues are what you do: the workplace skills you'd talk about when job-hunting. But eulogy virtues are who you are: what people will say about you at your funeral.
HCPLive
MARCH 24, 2024
Presence of nephritis in SLE patients is linked to higher cardiovascular risk factors and 3-fold increase in incidence of cardiovascular mortality.
Medical Xpress - Cardiology
MARCH 24, 2024
Microplastics and nanoplastics are everywhere in our environment—including in our oceans and lakes, farmland, and even Arctic ice algae.
HCPLive
MARCH 24, 2024
A significant association between Lp(a) and adverse cardiovascular outcomes was altered by renal function in patients undergoing percutaneous coronary intervention.
Frontiers in Cardiovascular Medicine
MARCH 24, 2024
Background The relationship between gut microbiota composition and coronary heart disease (CHD) has been recently reported in several observational studies. However, the causal effect of gut microbiota on coronary heart disease is uncharted. Objective This study attempted to investigate the effect of gut microbiota on coronary heart disease by Mendelian randomization (MR) analysis.
CardiacWire
MARCH 24, 2024
Less than two weeks after Novo Nordisk’s weight-loss drug Wegovy gained expanded FDA approval for cardiovascular event risk reduction, CMS issued a new Medicare Part D guidance that allows coverage of obesity drugs for senior patients with “an additional medically accepted indication”… like cardiovascular disease. Medicare Part D is administered through private payers, and is intended to help Medicare beneficiaries pay for self-administered prescription drugs.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Dr. Paddy Barrett
MARCH 24, 2024
The Heart Health Formula is everything I have learned over the last 20 years in clinical practice to: Understand Heart Disease Define Heart Disease Risk Reduce The Risk of Heart Disease This is the formula I use for myself and for my patients. There is a history of early heart disease in my own family, so I am very conscious about doing everything I can to reduce my future risk.
HCPLive
MARCH 24, 2024
This segment of Cohen’s interview from AAD covered the other talk given by Cohen titled ‘Knowing Lichenoid Dermatoses: Common Pathways and Treatments.
Journal of Cardiovascular Pharmacology
MARCH 24, 2024
Abstract: Sepsis-induced myocardial dysfunction (SIMD) commonly occurs in individuals with sepsis and is a severe complication with high morbidity and mortality rates. The current study aimed to investigate the effects and potential mechanisms of the natural steroidal sapogenin ruscogenin (RUS) against lipopolysaccharide (LPS)-induced myocardial injury in septic mice.
Stroke Journal
MARCH 24, 2024
Stroke, Volume 55, Issue 4 , Page 801-811, April 1, 2024. Vascular contributions to cognitive impairment and dementia (VCID) is an all-encompassing term that describes cognitive impairment due to cerebrovascular origins. With the advancement of imaging and pathological studies, we now understand that VCID is often comorbid with Alzheimer disease. While researchers in the Alzheimer disease field have been working for years to establish and test blood-based biomarkers for Alzheimer disease diagnos
Journal of Cardiovascular Pharmacology
MARCH 24, 2024
Abstract: To synthesize the available evidence regarding differences in the long-term safety and efficacy of intermittent, repeated, or continuous palliative inotropic therapy among patients with advanced heart failure (HF). We systematically searched the PubMed, Embase, and Cochrane Library electronic databases, with a cutoff date of November 23, 2023, for studies reporting outcomes in adult patients with advanced HF treated with intermittent, repeated, or continuous levosimendan, milrinone, or
The American Journal of Cardiology
MARCH 24, 2024
Publication date: Available online 23 March 2024 Source: The American Journal of Cardiology Author(s): Sara Sakowitz, Syed Shahyan Bakhtiyar, Joanna Curry, Saad Mallick, Amulya Vadlakonda, Konmal Ali, Yas Sanaiha, Peyman Benharash
Journal of Cardiovascular Pharmacology
MARCH 24, 2024
Abstract: Type 2 Diabetes Mellitus (T2DM) increases the risk of cardiovascular diseases. Therefore, elucidation of the cardiovascular effects of antidiabetics is crucial. Incretin-based therapies are increasingly used for T2DM treatment as monotherapy and in combination. We aimed to study the effects of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) and sitagliptin on beating rates in isolated atria from diabetic rats.
All About Cardiovascular System and Disorders
MARCH 24, 2024
Windkessel effect is applicable to large elastic arteries like aorta, which are situated close to the heart. They have more of elastic tissue than muscular tissue. The term Windkessel comes from German language and means air chamber. Here is an illustration of the Windkessel, used in 18th century, by fire fighters. The additional pressure built up in the air chamber will ensure continuous delivery of water for fire fighting.
Journal of Cardiovascular Pharmacology
MARCH 24, 2024
Abstract: This study seeks to identify the anticoagulant efficacy of rivaroxaban treatment on thrombi detected using echocardiography of the left atrial appendage in 275 patients with persistent atrial fibrillation (AF). During follow-up after 9 to 24 weeks of Rivaroxaban treatment, patients were divided into ‘effective group’ (n = 143) and ‘ineffective group’ (n = 132) according to the thrombolytic effect of the drug.
The American Journal of Cardiology
MARCH 24, 2024
The Universal definition (UD) of Myocardial Infarction (MI) has been an important contribution to the literature and has, among other aims, helped exp…
Circulation
MARCH 24, 2024
Circulation, Volume 149, Issue 13 , Page 973-978, March 26, 2024.
Stroke Journal
MARCH 24, 2024
Stroke, Volume 55, Issue 4 , Page e119-e120, April 1, 2024.
Circulation
MARCH 24, 2024
Circulation, Volume 149, Issue 13 , Page e1027-e1027, March 26, 2024.
Stroke Journal
MARCH 24, 2024
Stroke, Volume 55, Issue 4 , Page e131-e131, April 1, 2024.
Circulation
MARCH 24, 2024
Circulation, Volume 149, Issue 13 , Page e1023-e1023, March 26, 2024.
Stroke Journal
MARCH 24, 2024
Stroke, Volume 55, Issue 4 , Page 787-787, April 1, 2024.
Circulation
MARCH 24, 2024
Circulation, Volume 149, Issue 13 , Page e1024-e1024, March 26, 2024.
Stroke Journal
MARCH 24, 2024
Stroke, Volume 55, Issue 4 , Page 785-786, April 1, 2024.
Circulation
MARCH 24, 2024
Circulation, Volume 149, Issue 13 , Page e1025-e1025, March 26, 2024.
Stroke Journal
MARCH 24, 2024
Stroke, Volume 55, Issue 4 , Page 919-920, April 1, 2024.
Circulation
MARCH 24, 2024
Circulation, Volume 149, Issue 13 , Page e1026-e1026, March 26, 2024.
Stroke Journal
MARCH 24, 2024
Stroke, Volume 55, Issue 4 , Page 788-790, April 1, 2024.
Circulation
MARCH 24, 2024
Circulation, Volume 149, Issue 13 , Page 1016-1018, March 26, 2024.
Circulation
MARCH 24, 2024
Circulation, Volume 149, Issue 13 , Page 989-992, March 26, 2024.
Circulation
MARCH 24, 2024
Circulation, Volume 149, Issue 13 , Page 979-980, March 26, 2024.
Expert insights. Personalized for you.
119 
Let's personalize your content